首页> 外文期刊>Chinese Jouranl of Integrative Medicine >An Experiment on Standardized Cell Culture Assay in Assessing the Activities of Composite Artemisia Capillaris Tablets against Hepatitis B Virus Replication in vitro
【24h】

An Experiment on Standardized Cell Culture Assay in Assessing the Activities of Composite Artemisia Capillaris Tablets against Hepatitis B Virus Replication in vitro

机译:标准化细胞培养法评估复方蒿蒿片抗乙型肝炎病毒复制活性的实验

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To explore the activities of Composite Artemisia Capillaris Tablet (CACT) against hepatitis B virus replication in vitro. Methods: By means of radioimmunoassay (RIA), Dot blot and Southern blot, the surface and e antigen production of 2. 2. 15 cells, HBV DNA in 2. 2. 15 cell culture medium and that in 2. 2. 15 cells were examined respectively. Results: HBsAg, HBeAg values of 2. 2. 15 cells treated by CACT were lower than those of the control, the HBV DNA quantities in culture medium and in 2. 2. 15 cells decreased as compared with those cells with no treatment by CACT given to them. Conclusion: CACT could inhibit HBV DNA replication, showing its potential antiviral activity in hepatitis B treatment.
机译:目的:探讨复方蒿蒿片(CACT)体外抗乙型肝炎病毒复制的活性。方法:通过放射免疫分析(RIA),Dot印迹和Southern印迹,分别在2. 2. 15细胞培养基和2. 2. 15细胞培养基中分别产生2. 2. 15细胞和HBV DNA的表面和e抗原。分别进行了检查。结果:经CACT处理的2. 2. 15细胞的HBsAg,HBeAg值均低于对照组,与未经CACT处理的细胞相比,培养基和2. 2. 15细胞的HBV DNA数量下降。给他们。结论:CACT可抑制HBV DNA复制,显示其在乙肝治疗中的潜在抗病毒活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号